Beleslin D B, Rezvani A H, Myers R D
Brain Res Bull. 1986 Sep;17(3):379-85. doi: 10.1016/0361-9230(86)90241-8.
The anterior hypothalamic preoptic area (AH/POA) was examined as a possible site of action of clonidine and other alpha noradrenergic receptor agonists which evoke motor and autonomic changes. Chronically indwelling guide cannulae were implanted stereotaxically in the diencephalon of the cat. Following post-operative recovery, a micro-injection into AH/POA was made in a volume of 1.0 microliter of one of the following compounds: 5.0-50.0 micrograms clonidine, 5.0-50.0 micrograms norepinephrine, 5.0-50.0 micrograms phenylephrine and 5.0-50.0 micrograms methoxamine. The smallest dose of 5.0 micrograms clonidine produced a brief period of restlessness, licking, retching and emesis but a much longer-lasting mydriasis. When the dose of clonidine was raised to 20 micrograms, the cat became behaviorally sedated, after a latency of about 15 min, for a period of up to 1.0-2.0 hr. This was accompanied by a prolonged period of mydriasis and preceded by a short interval of restlessness, licking, retching and emesis. After the highest dose of 50.0 micrograms clonidine was micro-injected in AH/POA, a profound impairment of motor activity, adynomia and restlessness developed within 15-20 min, persisted for 30 to 60 min and was accompanied also by mydriasis with maximal pupillary dilation lasting for up to six hr. When 5.0-50.0 micrograms phenylephrine or 5.0-50.0 micrograms norepinephrine were micro-injected at clonidine-reactive sites in AH/POA, only rarely were brief instances of restlessness, licking, retching and emesis observed; however, methoxamine at all doses tested failed to produce any visible signs of autonomic or motor disturbance.(ABSTRACT TRUNCATED AT 250 WORDS)
研究了下丘脑视前区前部(AH/POA)作为可乐定及其他能引起运动和自主神经变化的α-去甲肾上腺素能受体激动剂的可能作用部位。将慢性留置引导套管立体定向植入猫的间脑。术后恢复后,向AH/POA微量注射1.0微升下列化合物之一:5.0 - 50.0微克可乐定、5.0 - 50.0微克去甲肾上腺素、5.0 - 50.0微克去氧肾上腺素和5.0 - 50.0微克甲氧明。最小剂量5.0微克可乐定可产生短暂的不安、舔舐、干呕和呕吐,但瞳孔散大持续时间更长。当可乐定剂量增至20微克时,猫在约15分钟的潜伏期后出现行为镇静,持续长达1.0 - 2.0小时。这伴有瞳孔散大延长,之前有短暂的不安、舔舐、干呕和呕吐。在AH/POA微量注射最高剂量50.0微克可乐定后,15 - 20分钟内出现运动活动严重受损、肌无力和不安,持续30至60分钟,同时伴有瞳孔散大,最大瞳孔扩张持续长达6小时。当在AH/POA中可乐定反应部位微量注射5.0 - 50.0微克去氧肾上腺素或5.0 - 50.0微克去甲肾上腺素时,仅偶尔观察到短暂的不安、舔舐、干呕和呕吐;然而,所有测试剂量的甲氧明均未产生任何自主神经或运动紊乱的明显迹象。(摘要截短于250字)